HIV preexposure prophylaxis in Canadian primary care and community settings

Can Fam Physician. 2019 Apr;65(4):271-272.

Authors

Amila Heendeniya¹, Ethan Tumarkin², Isaac I Bogoch³

Affiliations

¹ Infectious disease resident, University of Toronto in Ontario.
² Completing residency in internal medicine, University of Toronto in Ontario.
³ Associate Professor in the Department of Medicine at the University of Toronto, a staff physician in the Division of Internal Medicine and Infectious Diseases with the University Health Network in Toronto, and the lead physician at the HIV Prevention Clinic at Toronto General Hospital.

PMID: 30979761
PMCID: PMC6467657

No abstract available

MeSH terms

Anti-HIV Agents / therapeutic use*
Canada
Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination / therapeutic use*
HIV Infections / drug therapy
HIV Infections / prevention & control*
Humans
Pre-Exposure Prophylaxis / methods*
Primary Health Care / methods
Risk Factors

Substances

Anti-HIV Agents
Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination